200 related articles for article (PubMed ID: 33567424)
1. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
2. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
3. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
4. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
5. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
6. Network topology metrics explaining enrichment of hybrid epithelial/mesenchymal phenotypes in metastasis.
Rashid M; Hari K; Thampi J; Santhosh NK; Jolly MK
PLoS Comput Biol; 2022 Nov; 18(11):e1010687. PubMed ID: 36346808
[TBL] [Abstract][Full Text] [Related]
7. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
8. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H
Front Oncol; 2015; 5():155. PubMed ID: 26258068
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype.
Sahoo S; Nayak SP; Hari K; Purkait P; Mandal S; Kishore A; Levine H; Jolly MK
Front Immunol; 2021; 12():797261. PubMed ID: 34975907
[TBL] [Abstract][Full Text] [Related]
10. OVOL guides the epithelial-hybrid-mesenchymal transition.
Jia D; Jolly MK; Boareto M; Parsana P; Mooney SM; Pienta KJ; Levine H; Ben-Jacob E
Oncotarget; 2015 Jun; 6(17):15436-48. PubMed ID: 25944618
[TBL] [Abstract][Full Text] [Related]
11. Testing the gene expression classification of the EMT spectrum.
Jia D; George JT; Tripathi SC; Kundnani DL; Lu M; Hanash SM; Onuchic JN; Jolly MK; Levine H
Phys Biol; 2019 Jan; 16(2):025002. PubMed ID: 30557866
[TBL] [Abstract][Full Text] [Related]
12. Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology.
Pasani S; Sahoo S; Jolly MK
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375334
[TBL] [Abstract][Full Text] [Related]
13. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.
Bocci F; Jolly MK; Tripathi SC; Aguilar M; Hanash SM; Levine H; Onuchic JN
J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187638
[TBL] [Abstract][Full Text] [Related]
14. Stability and mean residence times for hybrid epithelial/mesenchymal phenotype.
Biswas K; Jolly MK; Ghosh A
Phys Biol; 2019 Jan; 16(2):025003. PubMed ID: 30537698
[TBL] [Abstract][Full Text] [Related]
15. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition.
Subbalakshmi AR; Sahoo S; Manjunatha P; Goyal S; Kasiviswanathan VA; Mahesh Y; Ramu S; McMullen I; Somarelli JA; Jolly MK
J Biol Eng; 2023 Mar; 17(1):17. PubMed ID: 36864480
[TBL] [Abstract][Full Text] [Related]
16. Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes.
Subbalakshmi AR; Ashraf B; Jolly MK
Phys Biol; 2022 Feb; 19(2):. PubMed ID: 34986465
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
Song IH; Kim KR; Lim S; Kim SH; Sung CO
Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
[TBL] [Abstract][Full Text] [Related]
19. Slug and E-Cadherin: Stealth Accomplices?
Sterneck E; Poria DK; Balamurugan K
Front Mol Biosci; 2020; 7():138. PubMed ID: 32760736
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
Sample RA; Nogueira MF; Mitra RD; Puram SV
Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
